igf-1 lr3 risks hypoglycemia organ growth Dietary or pharmacological inhibition of insulin-like factor-1 protects from renal ischemia-reperfusion injury in mice: iScience Modifying IGF1 activity: an approach
Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer Nature Reviews Drug Discovery Over stimulation of insulin IGF 1 signaling by Western diet may promote diseases of civilization: lessons learnt from Laron syndrome Nutrition & Metabolism Springer Nature Link Frontiers Insulin like growth factor 1 signaling in the tumor microenvironment: Carcinogenesis, cancer drug resistance, and therapeutic potential Insulin like growth factor 1 deficiency and metabolic syndrome PMC
Pay in 4 interest-free payments of $6.97 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15



